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1,9-Dideoxyforskolin hibits proteoglycan synthesis and xyloside-initiated glycosaminoglycan (GAG) synthesis in chick embryo chondrocytes. Di- 
deoxyforskolin does not affect the length of xyloside-initiated GAG chains secreted into the medium but chains from the dense proteoglycan secreted 
into the medium appear slightly longer. Incorporation of labeled serine into the dense proteoglycan and subsequent digestion with Pronase revealed 
a dramatic decrease in percent of total radioactivity associated with GAG chains in the proteoglycan from cultures treated with forskolin or dideoxy- 
forskolin. These observations uggest hat these diterpenes have a specific inhibitory effect on chain initiation reactions and thus may be useful 
tools in the study of proteoglycan synthesis and processing. 
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1. INTRODUCTION 
We have recently shown that forskolin inhibits pro- 
teoglycan synthesis as determined by both sulfate and 
glucosamine incorporation and results in shorter 
glycosaminoglycan (GAG) chains when initiation is on 
an artificial B,D-xyloside acceptor [1,2]. These effects 
occur in a concentration range well above that required 
to elicit a maximum response in elevation of CAMP and 
are not a consequence of impaired cellular energy 
metabolism [l]. We therefore thought that related lab- 
dane diterpenes might prove to be inhibitors of specific 
steps in proteoglycan synthesis and that a non-CAMP 
agonistic analog would more clearly separate the direct 
effects of these compounds from indirect, CAMP- 
mediated effects. Compounds inhibiting specific steps 
in the biosynthesis of proteoglycans would facilitate our 
understanding of proteoglycan synthesis as has recently 
been accomplished with specific inhibitors of glycopro- 
tein processing [3]. 
2. MATERIALS AND METHODS 
2.1. Cell culture conditions 
Chondrocyte cultures were established from the sternae of 1Cday 
chick embryos in Ham’s F-12 (GIBCO Laboratories, Grand Island, 
NY) medium and incubated as previously described [l]. 
2.2. Incorporation of sulfur-35 suifate into macromolecules 
Four-day-old cultures were incubated in Ham’s F-12 medium with 
35S04-2, (amount specified in figure legends), ICN Biomedicals, lr- 
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vine, CA) and insulin-like growth factor I (IGF-I), (20 ng/ml, Incell, 
Milwaukee, WI) and various concentrations of forskolin, (Sigma, St. 
Louis, MO), or 1,9-dideoxyforskolin (Calbiochem, San Diego, CA), 
for 8 h as previously described [1,2]. In some cases 4-methylumbel- 
liferyl-B,D-xyloside (0.16 mM) was also present. After incubation the 
total culture (cells plus medium) was extracted with 2 M 
guanidine-1% Zwittergent overnight at 4°C in the presence of pro- 
tease inhibitors [4]. After exhaustive dialysis against 0.1 M NaCI-1 
mM NazS04, the non-dialyzable radioactivity remaining in the 
dialysis bag was quantitated by liquid scintillation spectroscopy. Ex- 
periments using [‘Hlserine (Du Pont Co., NEN Res. Prod., Boston, 
MA) did not involve extraction, only medium was used. 
2.3, Dissociative CsCl density gradient centrtfugation 
The medium was dialyzed for 72 h against 4 liters of 0.1 M NaCI-1 
mM NazSO., containing protease inhibitors at one-tenth the usual 
concentration at 4°C with 4 changes of dialyzing medium, lyophilized 
and dissolved in dissociative CsCl buffer (4 M guanidine HCI in 0.1 
M Na acetate, pH 5.8, density 1.5 g/ml) containing protease in- 
hibitors [5]. This solution was centrifuged for 48 h at 160,000 x g at 
10°C and then fractionated into 4 parts from the most dense (bottom 
of the tube), to the least dense. Density of the DI fractions was > 1.57 
g/ml. 
2.4. Isolation of xyloside-initiated GAG chains from the medium 
Following incubation of cultures in the presence of 0.16 mM 
4-methylumbelliferyl B,D-xyloside (MUDX, Sigma, St. Louis, MO), 
35S04 - 2 with and without dideoxyforskolin the medium was dialyz- 
ed, lyophilized and chromatographed on Sepharose CL-6B as 
previously described [2]. 
2.5. Chromatography on Sepharose CL-2B 
Chromatography on CL-2B was carried out on a 0.9 x 90 cm col- 
umn equilibrated with 4 M guanidine in 0.1 M Na acetate, pH 5.8. 
2.6. Measurement of protein 
Protein was measured by the dye binding procedure of Bradford 
I61. 
2.7. Alkaline borohydride limination and reduction 
Proteoglycans from pooled fractions of CL-2B columns were 
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dialyzed to remove guanidine and were treated with 1 M sodium 
borohydride in 0.05 N NaOH for 48 h at 45°C [7]. Excess 
borohydride was decomposed with acetic acid and the samples were 
concentrated by lyophilization prior to chromatography. 
2.8. Measurement of ATP, lactate and CAMP 
These compounds were measured as previously described [l]. 
60 -- 
2.9. Pronase digestion 
After dialysis to remove guanidine, material to be digested was 
lyophilized and dissolved in 1 ml 50 mM Tris buffer, 1.5 mM CaC12, 
pH 7.2 and incubated with Pronase (1.5 mg) for 16 h at 37°C [8,9]. 
Pronase was added to the digest two additional times during the in- 
cubation. 
3. RESULTS 
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3.1. Effect of dideoxyforskolin on cellular metabolism 
Experiments similar to those previously reported [l] 
were conducted to evaluate the possible inhibitory ef- 
fects of dideoxyforskolin on chondrocyte metabolism. 
After 8 h exposure to 100 PM dideoxyforskolin, cellular 
ATP was 92% of control and not different from control 
values. Likewise, lactate accumulation in the medium 
was 91% of control, a slight decrease, but not as great 
as observed with forskolin [I]. Similarly, the protein 
content of cultures was identical after 8 h exposure to 
dideoxyforskolin. Thus, like forskolin, this diterpene is 
not toxic to embryonic chondrocyte cell cultures. Fur- 
ther, 7 h exposure to this non-CAMP agonistic analog 
did not increase accumulation of CAMP. 
Fig. 1. Effect of forskolin and dideoxyforskolin on proteoglycan 
synthesis. The cultures were incubated 8 h in the presence of ‘sSO4 - ’ 
and the indicated concentrations of forskolin or dideoxyforskolin and 
total proteoglycans extracted with guanidine-zwittergent. The 
extracts were dialyzed exhaustively and their content of radioactivity 
determined. Sixteen&i per culture (3 ml, 25 cm2 flasks) were present 
in the forskolin experiment and 30 &i per culture were present in the 
dideoxyforskolin experiment. Control values were 154,000 
cpm/culture and 477,000 cpm/culture, respectively. Data are 
expressed as means f SEM of 3 replicates. 0, forskolin; 0, 
dideoxyforskolin. 
3.2. Effect of dideoxy forskolin on incorporation 
of sulfate into total culture macromolecules 
A dose-response relationship for the effect of dide- 
oxyforskolin on incorporation of 3sS04 - 2 into total 
culture macromolecules is presented in Fig. 1. Inhibi- 
tion of incorporation is apparent between 1 and 100 PM 
where inhibition reaches 75%. For comparative pur- 
poses, data from an identical experiment with forskolin 
are included. A direct comparison indicates that 50% 
inhibition of incorporation is obtained at a concentra- 
tion of forskolin of about 80 PM whereas with dideoxy- 
forskolin it occurs at about 30 pM. Thus, dideoxyfor- 
skolin is about 2.7 times as effective as an inhibitor as 
is forskolin. The results obtained in this experiment 
with forskolin agree with those previously published 
t11. 
3.3. Effect of dideoxyforskolin on the synthesis of 
sulfated GAG chains initiated on an artificial 
xyloside acceptor 
dideoxyforskolin incorporation was reduced to 295,000 
cpm. When the extracts from the cultures containing 
the xyloside were chromatographed on Sepharose 
CLdB, a comparison of the radioactivity recovered in 
the GAG chain region (& = 0.2-0.8) from the 
chromatograms for control and treated cultures reveal- 
ed that the inhibition of incorporation was 73% which 
agrees with the 75% inhibition noted before the samples 
were pooled and chromatographed. Additional similar 
experiments were conducted except that the sulfated, 
xyloside-initiated GAG chains were recovered from the 
medium rather than from the medium plus cells. 
Typical elution profiles are shown in Fig. 2. Extensive 
control experiments have established that in the absence 
of a xyloside acceptor, all of the macromolecular 
radioactivity from sulfate elutes at the void volume of 
these columns as expected for a large proteoglycan. 
These sulfated GAG chains chromatograph similarly to 
chains isolated from the medium of cultures exposed to 
forskolin except hat the peak K,, value for chains from 
treated cultures is.not larger than controls. (Forskolin 
results in chains with a smaller hydrodynamic radius 
PI -1 
When the artificial acceptor 4-methyl umbelliferyl- 3.4. Effect of dideoxyforskolin on synthesis of dense 
B,D-xyloside is included in the medium incorporation is proteoglycans secreted into the medium 
stimulated and this incorporation, too, is inhibited by In order to focus further studies on a more specific 
dideoxyforskolin. In an experiment conducted class of proteoglycans, we examined the dense pro- 
simultaneously with the dideoxyforskolin experiment teoglycans secreted into the culture medium in the 
shown in Fig. 1, the B-xyloside stimulated incorpora- presence and absence of dideoxyforskolin by subjecting 
tion of 3sS04 - 2 over two-fold (477,000 cpm/culture vs dialyzed, lyophilized culture medium to dissociative 
1,116,OOO cpm/culture) but in the presence of 100 PM CsCl density gradient centrifugation [ 161. Data 
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Fig. 2. Effect of dideoxyforskolin on synthesis and size of xyloside- 
initiated GAG chains. The figure displays the elution profiles for 
sulfated GAG chains initiated on a B-xyloside and chromatographed 
on Sepharose CL-6B. In each case, the material chromatographed 
represents 3 cultures. 0, control; A , dideoxyforskolin-treated (100 
FM). The solid line represents data similar to those previously 
published [2] showing the elution position of chains formed in the 
presence of forskolin. 
resented in Fig. 3 demonstrate that incorporation of psso4-2~ mto the most dense proteoglycans ecreted in- 
to the medium (the Di fraction of CsCl dissociative den- 
sity gradient centrifugations) is inhibited by dideoxyfor- 
skolin. It is evident from this figure that inhibition is 
most pronounced for the larger species eluting from the 
column at K,, c 0.5. In addition, the hydrodynamic 
radius of the proteoglycans from cultures treated with 
dideoxyforskolin tends to be slightly smaller than con- 
trols. This difference is most readily apparent in the 
bottom panel of Fig. 3 in which the cumulative percent 
of total macromolecular adioactivity eluted between 
K,, = 0 and 0.8 is plotted against the K,, value. 
3.5. Effect of dideoxyforskolin on length of pro- 
teoglycan GAG chains 
In order to determine the structural basis for the 
decreased hydrodynamic radius of the proteoglycans, 
the material chromatographing between Kav = 0 and 
0.474 on the CL-2B columns was treated with alkaline 
borohydride to eliminate and reduce GAG chains. 
These chains were then chromatographed on Sepharose 
CL-6B to assess their relative hydrodynamic radius. 
The effect of the dideoxy analog on the length of GAG 
chains obtained from alkaline borohydride treatment of 
proteoglycan are shown in Fig. 4. It is obvious that 
chains are not shorter as a result of this treatment. In 
fact the treated cultures appear to produce a population 
of chains that are longer than chains from control 
cultures. 
3.6. Effect of the diterpenes on number of chains 
A likely explanation for the slightly smaller 
hydrodynamic radius of the intact proteoglycan in the 
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Fig. 3. Effect of dideoxyforskolin on synthesis and size of dense 
secreted proteoglycan. Cultures were incubated for 8 h in the presence 
of 100 PM forskolin and 4.3 &i/ml of radioactive sulfate. The 
medium was dialyzed, lyophilized and fractionated according to 
density. The Dt fraction from dissociative CsCl density gradient 
centrifugation was chromatographed on Sepharose CL-2B and the 
radioactivity of each fraction determined. Media from 3 cultures (7 
ml, 75 cm* flasks) were pooled. o, control; 0, dideoxyforskolin. Data 
are presented two ways for clarity; in the top panel as conventional 
elution profiles (cpm/ml vs K.,) and in the bottom panel as percent of 
total radioactivity eluted between 'K,,, = 0 and 0.8 vs the K., value. 
face of slightly longer GAG chains is that there are 
fewer chains per core protein molecule in the pro- 
teoglycans synthesized in the presence of dideoxyfor- 
skolin. To test this hypothesis, we metabolically labeled 
the secreted proteoglycans with tritiated serine, isolated 
the Di fraction by density gradient centrifugation, 
chromatographed this on 2B as before and digested the 
proteoglycans eluting between Kav = 0 and 0.59 with 
Pronase. The digest was subsequently chromatograph- 
ed on Sepharose CLdB. GAG chains end-labeled with 
serine-3H elute in the same position as the “S-sulfate 
labeled GAG chains. Lower molecular weight digestion 
products elute at or near the total column volume. 
Therefore, the percentage of tritium that 
chromatographs as a macromolecule in the GAG chain 
region is a measure of the relative chain number in com- 
paring treated and control cultures. The results of 
chromatography of the Pronase digests are shown in 
102 
Volume 270, number 1,2 FEBS LETTERS September 1990 
0.0 0.2 0.4 0.6 
Kav value 
0.8 1.0 
Fig. 4. Effect of dideoxyforskolin on size of GAG chains from dense 
proteoglycan. The material from the 2B column in Fig. 3 (KaV = 
o-0.474) was treated with alkaline borohydride and chromatographed 
on Sepharose CL-6B as described in the text. o, control; 0, 
dideoxyforskolin. 
Fig. 5. In the control, 50% of the radioactivity elutes at 
a Kav value smaller than 0.68, in forskolin-treated 
cultures the value is 0.94 and for dideoxyforskolin the 
point of 50% elution is reached at a Kav value of 0.98. 
There is, therefore, a considerable reduction in the frac- 
tion of serine attached to GAG chains in the two rreated 
groups, consistent with a reduction in the number of 
chains per core protein. Of 168,000 cpm 
chromatographed in the control column, 60% were 
recovered in the Kav = 0.2-0.8 fractions. 71,000 cpm 
were chromatographed from the forskolin-treated 
group and 39% were recovered in these fractions. 
Similarly, from the dideoxyforskolin group, 21% of the 
52,000 cpm chromatographed were recovered in the 
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Fig. 5. Effect of forskolin and dideoxyforskolin on number of chains 
on large dense proteoglycan secreted into the medium. Large, dense 
proteoglycan was isolated from the medium of cultures metabolically 
labeled with [3H]serine (11.7 @i/ml for 8 h) by density gradient 
centrifugation and Sepharose CL-2B chromatography as described in 
the text. Proteoglycan between Kay = 0 and 0.59 was dialyzed and 
digested with Pronase. The Pronase digest was chromatographed on 
Sepharose CLdB and the tritium measured. The data are expressed as 
cumulative 070 eluted, plotted vs K,,. Media from 4 cultures (7 ml, 75 
cm2 flasks) cultures were pooled for each group. o, control; 9, 1OOpM 
forskolin; A , 100 pM dideoxyforskolin. 
0.2-0.8 Kav fractions. These data indicate a reduction in 
chain number by forskolin of about 33% and by 
dideoxyforskolin of about 60%. 
4. DISCUSSION 
The results of this investigation together with other 
recently published results from our laboratory [1,2] 
clearly establish an inhibitory effect of the labdane 
diterpenes, the CAMP agonistic forskolin [lo, 1 l] and 
the non-agonistic, 1,9-dideoxyforskolin [11,121 on pro- 
teoglycan synthesis in embryonic chick sternum chon- 
drocyte cultures. Thus proteoglycan synthesis is added 
to the increasing list of CAMP independent cellular ef- 
fects of forskolin [ 13-191. Both compounds are 
markedly inhibitory for sulfate incorporation, both 
result in a reduction in the number of chains per core 
protein molecule and both inhibit the synthesis of 
sulfated GAG chains initiated on an artificial B- 
xyloside. 
The structural modifications in proteoglycans reveal- 
ed by chromatographic analysis are more dramatic in 
the case of the dideoxy analog. A greater proportion of 
labeled proteoglycan molecules are present in the 
smaller molecular weight range with the analog than 
with forskolin. Also, the GAG chains from the pro- 
teoglycans of analog-treated cultures are slightly longer 
than controls even though synthesis is more severely in- 
hibited. Similarly, dideoxyforskolin does not result in 
shorter xyloside-initiated GAG chains as does for- 
skolin. These two observations are consistent with a 
slower overall rate of processing with the analog that 
somehow allows chains to reach normal or greater 
lengths as compared to those synthesized by control or 
forskolin-treated cultures. The idea of competition for 
available acceptor sites as one determinant of chain 
length has been previously suggested [20]. The decreas- 
ed chain number in analog-treated cultures effectively 
decreases the concentration of acceptor sites for chain 
synthesis. Presumably a slower rate of chain synthesis 
could decrease the effect of acceptor concentration on 
chain length. Our results are therefore compatible with 
slightly longer chains even though the proteoglycan 
molecules themselves are slightly smaller as a conse- 
quence of the reduced number of chains. 
The common denominators in chain initiation on 
core protein and artificial B-xylosides are the two galac- 
tosyl transferases and the first glucuronosyl transferase 
[21,22]. An inhibition of any of these enzymes, either 
directly or indirectly as a consequence of some par- 
ticular insult to the Golgi complex would explain the 
results herein. The chains that are initiated are process- 
ed normally even in the dideoxyforskolin-treated cells. 
Unprocessed core protein molecules may be degraded 
or may be involved in a feedback control loop that 
blocks further synthesis. In any case, they would not be 
detected by the methods employed in this study and it is 
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not surprising that inhibition of serine incorporation is 
roughly similar to inhibition of sulfate incorporation. 
All our observations are consistent with the hypothesis 
that these diterpenes inhibit one or more reactions of 
chain initiation common to both proteoglycan-GAG 
chains and xyloside-GAG chains. It appears that 
dideoxyforskolin and similar related compounds may 
prove to be useful tools for furthering our understan- 
ding of proteoglycan synthesis and processing. 
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